查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
性感染疾病(STD)检验的全球市场 2023-2027
市场调查报告书
商品编码
1165919

性感染疾病(STD)检验的全球市场 2023-2027

Global Sexually Transmitted Disease (STD) Testing Market 2023-2027
出版日期: | 出版商: TechNavio | 英文 120 Pages | 订单完成后即时交付

价格

性感染疾病(STD)检验的市场规模在2023年～2027年间，预测将成长到299亿8,827万美元，在预测期间内预计将以年复合成长率5.46％增长。本报告提供性感染疾病(STD)检验市场整体分析，市场规模·预测，趋势，成长促进因素·课题，网罗了约25供应商的供应商分析等资讯。

同时本报告还提供当前全球市场趋势与推动因素以及整体市场环境的最新分析。

市场成长的主要因素有STD的盛行率增加，有利的偿付政策存在，世界各国政府的举措增加。

目录

第1章 摘要整理

  • 市场概要

第2章 市场形势

  • 市场生态系统

第3章 市场规模

  • 市场定义
  • 市场区隔分析
  • 市场规模 2022
  • 市场预测:2022-2027年的预测

第4章 市场规模实际成果

  • 全球性感染疾病(STD)检验市场2017～2021年
  • 各产品市场区隔分析2017-2021
  • 各疾病类型市场区隔分析2017-2021
  • 各地区市场区隔分析2017-2021
  • 各国市场区隔分析2017-2021

第5章 波特的五力分析

  • 五力的摘要
  • 买方议价能力
  • 供给企业谈判力
  • 新加入厂商业者的威胁
  • 替代品的威胁
  • 竞争的威胁
  • 市场情况

第6章 各疾病类型市场区隔

  • 市场明细
  • 病型比较
  • 披衣菌感染 - 市场规模与预测 2022-2027
  • 淋病 - 市场规模与预测 2022-2027
  • 梅毒 - 市场规模与预测 2022-2027
  • 滴虫病 - 市场规模与预测 2022-2027
  • 其他 - 市场规模与预测 2022-2027
  • 各疾病的市场机会

第7章 各产品市场区隔

  • 市场明细
  • 各产品比较
  • 临床检查装置 - 市场规模与预测 2022-2027
  • POC实验设备 - 市场规模与预测 2022-2027
  • 各产品的市场机会

第8章 客户形势

  • 客户形势概要

第9章 各地区形势

  • 各地区市场区隔
  • 各地区比较
  • 北美 - 市场规模与预测 2022-2027
  • 欧洲 - 市场规模与预测 2022-2027
  • 亚洲 - 市场规模与预测 2022-2027
  • 其他地区(ROW) - 市场规模与预测 2022-2027
  • 美国 - 市场规模与预测 2022-2027
  • 德国 - 市场规模与预测 2022-2027
  • 英国 - 市场规模与预测 2022-2027
  • 加拿大 - 市场规模与预测 2022-2027
  • 中国 - 市场规模与预测 2022-2027
  • 各地区形势的市场机会

第10章 促进因素，课题，及趋势

  • 推动市场要素
  • 市场课题
  • 推动因素与课题的影响
  • 市场趋势

第11章 业者情势

  • 概要
  • 业者情势
  • 混乱状况
  • 产业的风险

第12章 供应商分析

  • 交易厂商
  • 供应商的市场定位
  • AbbVie Inc.
  • AccuBioTech Co. Ltd.
  • AdvaCare Pharma
  • BIOGENIX Inc. Pvt. Ltd.
  • F. Hoffmann La Roche Ltd.
  • Gilead Sciences Inc.
  • GlaxoSmithKline Plc
  • Hologic Inc.
  • Inovio Pharmaceuticals Inc.
  • Johnson and Johnson
  • Merck and Co. Inc.
  • OK Biotech Co. Ltd.
  • Priority STD Testing
  • QIAGEN NV
  • RayBiotech Life Inc.

第13章 附录

Product Code: IRTNTR70506

Technavio has been monitoring the sexually transmitted disease (STD) testing market and it is poised to grow by $29988.27 mn during 2023-2027, accelerating at a CAGR of 5.46% during the forecast period. Our report on the sexually transmitted disease (STD) testing market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the increasing prevalence of STDs, presence of favorable reimbursement policies, and increased initiatives by governments worldwide.

Technavio's sexually transmitted disease (STD) testing market is segmented as below:

By Disease Type

  • Chlamydia
  • Gonorrhea
  • Syphilis
  • Trichomoniasis
  • Others

By Product

  • Laboratory testing device
  • POC testing device

By Geographical Landscape

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)

This study identifies the advances in rapid diagnosis of STDs as one of the prime reasons driving the sexually transmitted disease (STD) testing market growth during the next few years. Also, increasing involvement of various organizations to create awareness about STDs and expedited partner therapy (EPT) will lead to sizable demand in the market.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on the sexually transmitted disease (STD) testing market covers the following areas:

  • Sexually transmitted disease (STD) testing market sizing
  • Sexually transmitted disease (STD) testing market forecast
  • Sexually transmitted disease (STD) testing market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading sexually transmitted disease (STD) testing market vendors that include AbbVie Inc., AccuBioTech Co. Ltd., AdvaCare Pharma, BIOGENIX Inc. Pvt. Ltd., CTK Biotech Inc., Everlywell Inc., F. Hoffmann La Roche Ltd., Gilead Sciences Inc., GlaxoSmithKline Plc, Goffin Molecular Technologies, Hangzhou Biotest Biotech Co. Ltd., Hologic Inc., Inovio Pharmaceuticals Inc., Johnson and Johnson, LT Labs, Merck and Co. Inc., OK Biotech Co. Ltd., Priority STD Testing, QIAGEN NV, and RayBiotech Life Inc. Also, the sexually transmitted disease (STD) testing market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

  • 1.1 Market overview
  • Exhibit 01: Executive Summary - Chart on Market Overview
  • Exhibit 02: Executive Summary - Data Table on Market Overview
  • Exhibit 03: Executive Summary - Chart on Global Market Characteristics
  • Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
  • Exhibit 05: Executive Summary - Chart on Market Segmentation by Disease Type
  • Exhibit 06: Executive Summary - Chart on Market Segmentation by Product
  • Exhibit 07: Executive Summary - Chart on Incremental Growth
  • Exhibit 08: Executive Summary - Data Table on Incremental Growth
  • Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
  • Exhibit 10: Parent market
  • Exhibit 11: Market Characteristics

3 Market Sizing

  • 3.1 Market definition
  • Exhibit 12: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis
  • Exhibit 13: Market segments
  • 3.3 Market size 2022
  • 3.4 Market outlook: Forecast for 2022-2027
  • Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
  • Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
  • Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
  • Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size

  • 4.1 Global sexually transmitted disease (STD) testing market 2017 - 2021
  • Exhibit 18: Historic Market Size - Data Table on Global sexually transmitted disease (STD) testing market 2017 - 2021 ($ million)
  • 4.2 Product Segment Analysis 2017 - 2021
  • Exhibit 19: Historic Market Size - Product Segment 2017 - 2021 ($ million)
  • 4.3 Disease type Segment Analysis 2017 - 2021
  • Exhibit 20: Historic Market Size - Disease type Segment 2017 - 2021 ($ million)
  • 4.4 Geography Segment Analysis 2017 - 2021
  • Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
  • 4.5 Country Segment Analysis 2017 - 2021
  • Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)

5 Five Forces Analysis

  • 5.1 Five forces summary
  • Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
  • 5.2 Bargaining power of buyers
  • Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
  • 5.3 Bargaining power of suppliers
  • Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
  • 5.4 Threat of new entrants
  • Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
  • 5.5 Threat of substitutes
  • Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
  • 5.6 Threat of rivalry
  • Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
  • 5.7 Market condition
  • Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by Disease Type

  • 6.1 Market segments
  • Exhibit 30: Chart on Disease Type - Market share 2022-2027 (%)
  • Exhibit 31: Data Table on Disease Type - Market share 2022-2027 (%)
  • 6.2 Comparison by Disease Type
  • Exhibit 32: Chart on Comparison by Disease Type
  • Exhibit 33: Data Table on Comparison by Disease Type
  • 6.3 Chlamydia - Market size and forecast 2022-2027
  • Exhibit 34: Chart on Chlamydia - Market size and forecast 2022-2027 ($ million)
  • Exhibit 35: Data Table on Chlamydia - Market size and forecast 2022-2027 ($ million)
  • Exhibit 36: Chart on Chlamydia - Year-over-year growth 2022-2027 (%)
  • Exhibit 37: Data Table on Chlamydia - Year-over-year growth 2022-2027 (%)
  • 6.4 Gonorrhea - Market size and forecast 2022-2027
  • Exhibit 38: Chart on Gonorrhea - Market size and forecast 2022-2027 ($ million)
  • Exhibit 39: Data Table on Gonorrhea - Market size and forecast 2022-2027 ($ million)
  • Exhibit 40: Chart on Gonorrhea - Year-over-year growth 2022-2027 (%)
  • Exhibit 41: Data Table on Gonorrhea - Year-over-year growth 2022-2027 (%)
  • 6.5 Syphilis - Market size and forecast 2022-2027
  • Exhibit 42: Chart on Syphilis - Market size and forecast 2022-2027 ($ million)
  • Exhibit 43: Data Table on Syphilis - Market size and forecast 2022-2027 ($ million)
  • Exhibit 44: Chart on Syphilis - Year-over-year growth 2022-2027 (%)
  • Exhibit 45: Data Table on Syphilis - Year-over-year growth 2022-2027 (%)
  • 6.6 Trichomoniasis - Market size and forecast 2022-2027
  • Exhibit 46: Chart on Trichomoniasis - Market size and forecast 2022-2027 ($ million)
  • Exhibit 47: Data Table on Trichomoniasis - Market size and forecast 2022-2027 ($ million)
  • Exhibit 48: Chart on Trichomoniasis - Year-over-year growth 2022-2027 (%)
  • Exhibit 49: Data Table on Trichomoniasis - Year-over-year growth 2022-2027 (%)
  • 6.7 Others - Market size and forecast 2022-2027
  • Exhibit 50: Chart on Others - Market size and forecast 2022-2027 ($ million)
  • Exhibit 51: Data Table on Others - Market size and forecast 2022-2027 ($ million)
  • Exhibit 52: Chart on Others - Year-over-year growth 2022-2027 (%)
  • Exhibit 53: Data Table on Others - Year-over-year growth 2022-2027 (%)
  • 6.8 Market opportunity by Disease Type
  • Exhibit 54: Market opportunity by Disease Type ($ million)

7 Market Segmentation by Product

  • 7.1 Market segments
  • Exhibit 55: Chart on Product - Market share 2022-2027 (%)
  • Exhibit 56: Data Table on Product - Market share 2022-2027 (%)
  • 7.2 Comparison by Product
  • Exhibit 57: Chart on Comparison by Product
  • Exhibit 58: Data Table on Comparison by Product
  • 7.3 Laboratory testing device - Market size and forecast 2022-2027
  • Exhibit 59: Chart on Laboratory testing device - Market size and forecast 2022-2027 ($ million)
  • Exhibit 60: Data Table on Laboratory testing device - Market size and forecast 2022-2027 ($ million)
  • Exhibit 61: Chart on Laboratory testing device - Year-over-year growth 2022-2027 (%)
  • Exhibit 62: Data Table on Laboratory testing device - Year-over-year growth 2022-2027 (%)
  • 7.4 POC testing device - Market size and forecast 2022-2027
  • Exhibit 63: Chart on POC testing device - Market size and forecast 2022-2027 ($ million)
  • Exhibit 64: Data Table on POC testing device - Market size and forecast 2022-2027 ($ million)
  • Exhibit 65: Chart on POC testing device - Year-over-year growth 2022-2027 (%)
  • Exhibit 66: Data Table on POC testing device - Year-over-year growth 2022-2027 (%)
  • 7.5 Market opportunity by Product
  • Exhibit 67: Market opportunity by Product ($ million)

8 Customer Landscape

  • 8.1 Customer landscape overview
  • Exhibit 68: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

  • 9.1 Geographic segmentation
  • Exhibit 69: Chart on Market share By Geographical Landscape 2022-2027 (%)
  • Exhibit 70: Data Table on Market share By Geographical Landscape 2022-2027 (%)
  • 9.2 Geographic comparison
  • Exhibit 71: Chart on Geographic comparison
  • Exhibit 72: Data Table on Geographic comparison
  • 9.3 North America - Market size and forecast 2022-2027
  • Exhibit 73: Chart on North America - Market size and forecast 2022-2027 ($ million)
  • Exhibit 74: Data Table on North America - Market size and forecast 2022-2027 ($ million)
  • Exhibit 75: Chart on North America - Year-over-year growth 2022-2027 (%)
  • Exhibit 76: Data Table on North America - Year-over-year growth 2022-2027 (%)
  • 9.4 Europe - Market size and forecast 2022-2027
  • Exhibit 77: Chart on Europe - Market size and forecast 2022-2027 ($ million)
  • Exhibit 78: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
  • Exhibit 79: Chart on Europe - Year-over-year growth 2022-2027 (%)
  • Exhibit 80: Data Table on Europe - Year-over-year growth 2022-2027 (%)
  • 9.5 Asia - Market size and forecast 2022-2027
  • Exhibit 81: Chart on Asia - Market size and forecast 2022-2027 ($ million)
  • Exhibit 82: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
  • Exhibit 83: Chart on Asia - Year-over-year growth 2022-2027 (%)
  • Exhibit 84: Data Table on Asia - Year-over-year growth 2022-2027 (%)
  • 9.6 Rest of World (ROW) - Market size and forecast 2022-2027
  • Exhibit 85: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
  • Exhibit 86: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
  • Exhibit 87: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
  • Exhibit 88: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
  • 9.7 US - Market size and forecast 2022-2027
  • Exhibit 89: Chart on US - Market size and forecast 2022-2027 ($ million)
  • Exhibit 90: Data Table on US - Market size and forecast 2022-2027 ($ million)
  • Exhibit 91: Chart on US - Year-over-year growth 2022-2027 (%)
  • Exhibit 92: Data Table on US - Year-over-year growth 2022-2027 (%)
  • 9.8 Germany - Market size and forecast 2022-2027
  • Exhibit 93: Chart on Germany - Market size and forecast 2022-2027 ($ million)
  • Exhibit 94: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
  • Exhibit 95: Chart on Germany - Year-over-year growth 2022-2027 (%)
  • Exhibit 96: Data Table on Germany - Year-over-year growth 2022-2027 (%)
  • 9.9 UK - Market size and forecast 2022-2027
  • Exhibit 97: Chart on UK - Market size and forecast 2022-2027 ($ million)
  • Exhibit 98: Data Table on UK - Market size and forecast 2022-2027 ($ million)
  • Exhibit 99: Chart on UK - Year-over-year growth 2022-2027 (%)
  • Exhibit 100: Data Table on UK - Year-over-year growth 2022-2027 (%)
  • 9.10 Canada - Market size and forecast 2022-2027
  • Exhibit 101: Chart on Canada - Market size and forecast 2022-2027 ($ million)
  • Exhibit 102: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
  • Exhibit 103: Chart on Canada - Year-over-year growth 2022-2027 (%)
  • Exhibit 104: Data Table on Canada - Year-over-year growth 2022-2027 (%)
  • 9.11 China - Market size and forecast 2022-2027
  • Exhibit 105: Chart on China - Market size and forecast 2022-2027 ($ million)
  • Exhibit 106: Data Table on China - Market size and forecast 2022-2027 ($ million)
  • Exhibit 107: Chart on China - Year-over-year growth 2022-2027 (%)
  • Exhibit 108: Data Table on China - Year-over-year growth 2022-2027 (%)
  • 9.12 Market opportunity By Geographical Landscape
  • Exhibit 109: Market opportunity By Geographical Landscape ($ million)

10 Drivers, Challenges, and Trends

  • 10.1 Market drivers
  • 10.2 Market challenges
  • 10.3 Impact of drivers and challenges
  • Exhibit 110: Impact of drivers and challenges in 2022 and 2027
  • 10.4 Market trends

11 Vendor Landscape

  • 11.1 Overview
  • 11.2 Vendor landscape
  • Exhibit 111: Overview on Criticality of inputs and Factors of differentiation
  • 11.3 Landscape disruption
  • Exhibit 112: Overview on factors of disruption
  • 11.4 Industry risks
  • Exhibit 113: Impact of key risks on business

12 Vendor Analysis

  • 12.1 Vendors covered
  • Exhibit 114: Vendors covered
  • 12.2 Market positioning of vendors
  • Exhibit 115: Matrix on vendor position and classification
  • 12.3 AbbVie Inc.
  • Exhibit 116: AbbVie Inc. - Overview
  • Exhibit 117: AbbVie Inc. - Product / Service
  • Exhibit 118: AbbVie Inc. - Key offerings
  • 12.4 AccuBioTech Co. Ltd.
  • Exhibit 119: AccuBioTech Co. Ltd. - Overview
  • Exhibit 120: AccuBioTech Co. Ltd. - Product / Service
  • Exhibit 121: AccuBioTech Co. Ltd. - Key offerings
  • 12.5 AdvaCare Pharma
  • Exhibit 122: AdvaCare Pharma - Overview
  • Exhibit 123: AdvaCare Pharma - Product / Service
  • Exhibit 124: AdvaCare Pharma - Key offerings
  • 12.6 BIOGENIX Inc. Pvt. Ltd.
  • Exhibit 125: BIOGENIX Inc. Pvt. Ltd. - Overview
  • Exhibit 126: BIOGENIX Inc. Pvt. Ltd. - Product / Service
  • Exhibit 127: BIOGENIX Inc. Pvt. Ltd. - Key offerings
  • 12.7 F. Hoffmann La Roche Ltd.
  • Exhibit 128: F. Hoffmann La Roche Ltd. - Overview
  • Exhibit 129: F. Hoffmann La Roche Ltd. - Business segments
  • Exhibit 130: F. Hoffmann La Roche Ltd. - Key news
  • Exhibit 131: F. Hoffmann La Roche Ltd. - Key offerings
  • Exhibit 132: F. Hoffmann La Roche Ltd. - Segment focus
  • 12.8 Gilead Sciences Inc.
  • Exhibit 133: Gilead Sciences Inc. - Overview
  • Exhibit 134: Gilead Sciences Inc. - Product / Service
  • Exhibit 135: Gilead Sciences Inc. - Key news
  • Exhibit 136: Gilead Sciences Inc. - Key offerings
  • 12.9 GlaxoSmithKline Plc
  • Exhibit 137: GlaxoSmithKline Plc - Overview
  • Exhibit 138: GlaxoSmithKline Plc - Business segments
  • Exhibit 139: GlaxoSmithKline Plc - Key offerings
  • Exhibit 140: GlaxoSmithKline Plc - Segment focus
  • 12.10 Hologic Inc.
  • Exhibit 141: Hologic Inc. - Overview
  • Exhibit 142: Hologic Inc. - Business segments
  • Exhibit 143: Hologic Inc. - Key news
  • Exhibit 144: Hologic Inc. - Key offerings
  • Exhibit 145: Hologic Inc. - Segment focus
  • 12.11 Inovio Pharmaceuticals Inc.
  • Exhibit 146: Inovio Pharmaceuticals Inc. - Overview
  • Exhibit 147: Inovio Pharmaceuticals Inc. - Product / Service
  • Exhibit 148: Inovio Pharmaceuticals Inc. - Key news
  • Exhibit 149: Inovio Pharmaceuticals Inc. - Key offerings
  • 12.12 Johnson and Johnson
  • Exhibit 150: Johnson and Johnson - Overview
  • Exhibit 151: Johnson and Johnson - Business segments
  • Exhibit 152: Johnson and Johnson - Key news
  • Exhibit 153: Johnson and Johnson - Key offerings
  • Exhibit 154: Johnson and Johnson - Segment focus
  • 12.13 Merck and Co. Inc.
  • Exhibit 155: Merck and Co. Inc. - Overview
  • Exhibit 156: Merck and Co. Inc. - Business segments
  • Exhibit 157: Merck and Co. Inc. - Key news
  • Exhibit 158: Merck and Co. Inc. - Key offerings
  • Exhibit 159: Merck and Co. Inc. - Segment focus
  • 12.14 OK Biotech Co. Ltd.
  • Exhibit 160: OK Biotech Co. Ltd. - Overview
  • Exhibit 161: OK Biotech Co. Ltd. - Product / Service
  • Exhibit 162: OK Biotech Co. Ltd. - Key offerings
  • 12.15 Priority STD Testing
  • Exhibit 163: Priority STD Testing - Overview
  • Exhibit 164: Priority STD Testing - Product / Service
  • Exhibit 165: Priority STD Testing - Key offerings
  • 12.16 QIAGEN NV
  • Exhibit 166: QIAGEN NV - Overview
  • Exhibit 167: QIAGEN NV - Product / Service
  • Exhibit 168: QIAGEN NV - Key news
  • Exhibit 169: QIAGEN NV - Key offerings
  • 12.17 RayBiotech Life Inc.
  • Exhibit 170: RayBiotech Life Inc. - Overview
  • Exhibit 171: RayBiotech Life Inc. - Product / Service
  • Exhibit 172: RayBiotech Life Inc. - Key offerings

13 Appendix

  • 13.1 Scope of the report
  • 13.2 Inclusions and exclusions checklist
  • Exhibit 173: Inclusions checklist
  • Exhibit 174: Exclusions checklist
  • 13.3 Currency conversion rates for US$
  • Exhibit 175: Currency conversion rates for US$
  • 13.4 Research methodology
  • Exhibit 176: Research methodology
  • Exhibit 177: Validation techniques employed for market sizing
  • Exhibit 178: Information sources
  • 13.5 List of abbreviations
  • Exhibit 179: List of abbreviations

Exhibits:

  • Exhibits1: Executive Summary - Chart on Market Overview
  • Exhibits2: Executive Summary - Data Table on Market Overview
  • Exhibits3: Executive Summary - Chart on Global Market Characteristics
  • Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
  • Exhibits5: Executive Summary - Chart on Market Segmentation by Disease Type
  • Exhibits6: Executive Summary - Chart on Market Segmentation by Product
  • Exhibits7: Executive Summary - Chart on Incremental Growth
  • Exhibits8: Executive Summary - Data Table on Incremental Growth
  • Exhibits9: Executive Summary - Chart on Vendor Market Positioning
  • Exhibits10: Parent market
  • Exhibits11: Market Characteristics
  • Exhibits12: Offerings of vendors included in the market definition
  • Exhibits13: Market segments
  • Exhibits14: Chart on Global - Market size and forecast 2022-2027 ($ million)
  • Exhibits15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
  • Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
  • Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
  • Exhibits18: Historic Market Size - Data Table on Global sexually transmitted disease (STD) testing market 2017 - 2021 ($ million)
  • Exhibits19: Historic Market Size - Product Segment 2017 - 2021 ($ million)
  • Exhibits20: Historic Market Size - Disease type Segment 2017 - 2021 ($ million)
  • Exhibits21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
  • Exhibits22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
  • Exhibits23: Five forces analysis - Comparison between 2022 and 2027
  • Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
  • Exhibits25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
  • Exhibits26: Threat of new entrants - Impact of key factors in 2022 and 2027
  • Exhibits27: Threat of substitutes - Impact of key factors in 2022 and 2027
  • Exhibits28: Threat of rivalry - Impact of key factors in 2022 and 2027
  • Exhibits29: Chart on Market condition - Five forces 2022 and 2027
  • Exhibits30: Chart on Disease Type - Market share 2022-2027 (%)
  • Exhibits31: Data Table on Disease Type - Market share 2022-2027 (%)
  • Exhibits32: Chart on Comparison by Disease Type
  • Exhibits33: Data Table on Comparison by Disease Type
  • Exhibits34: Chart on Chlamydia - Market size and forecast 2022-2027 ($ million)
  • Exhibits35: Data Table on Chlamydia - Market size and forecast 2022-2027 ($ million)
  • Exhibits36: Chart on Chlamydia - Year-over-year growth 2022-2027 (%)
  • Exhibits37: Data Table on Chlamydia - Year-over-year growth 2022-2027 (%)
  • Exhibits38: Chart on Gonorrhea - Market size and forecast 2022-2027 ($ million)
  • Exhibits39: Data Table on Gonorrhea - Market size and forecast 2022-2027 ($ million)
  • Exhibits40: Chart on Gonorrhea - Year-over-year growth 2022-2027 (%)
  • Exhibits41: Data Table on Gonorrhea - Year-over-year growth 2022-2027 (%)
  • Exhibits42: Chart on Syphilis - Market size and forecast 2022-2027 ($ million)
  • Exhibits43: Data Table on Syphilis - Market size and forecast 2022-2027 ($ million)
  • Exhibits44: Chart on Syphilis - Year-over-year growth 2022-2027 (%)
  • Exhibits45: Data Table on Syphilis - Year-over-year growth 2022-2027 (%)
  • Exhibits46: Chart on Trichomoniasis - Market size and forecast 2022-2027 ($ million)
  • Exhibits47: Data Table on Trichomoniasis - Market size and forecast 2022-2027 ($ million)
  • Exhibits48: Chart on Trichomoniasis - Year-over-year growth 2022-2027 (%)
  • Exhibits49: Data Table on Trichomoniasis - Year-over-year growth 2022-2027 (%)
  • Exhibits50: Chart on Others - Market size and forecast 2022-2027 ($ million)
  • Exhibits51: Data Table on Others - Market size and forecast 2022-2027 ($ million)
  • Exhibits52: Chart on Others - Year-over-year growth 2022-2027 (%)
  • Exhibits53: Data Table on Others - Year-over-year growth 2022-2027 (%)
  • Exhibits54: Market opportunity by Disease Type ($ million)
  • Exhibits55: Chart on Product - Market share 2022-2027 (%)
  • Exhibits56: Data Table on Product - Market share 2022-2027 (%)
  • Exhibits57: Chart on Comparison by Product
  • Exhibits58: Data Table on Comparison by Product
  • Exhibits59: Chart on Laboratory testing device - Market size and forecast 2022-2027 ($ million)
  • Exhibits60: Data Table on Laboratory testing device - Market size and forecast 2022-2027 ($ million)
  • Exhibits61: Chart on Laboratory testing device - Year-over-year growth 2022-2027 (%)
  • Exhibits62: Data Table on Laboratory testing device - Year-over-year growth 2022-2027 (%)
  • Exhibits63: Chart on POC testing device - Market size and forecast 2022-2027 ($ million)
  • Exhibits64: Data Table on POC testing device - Market size and forecast 2022-2027 ($ million)
  • Exhibits65: Chart on POC testing device - Year-over-year growth 2022-2027 (%)
  • Exhibits66: Data Table on POC testing device - Year-over-year growth 2022-2027 (%)
  • Exhibits67: Market opportunity by Product ($ million)
  • Exhibits68: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Exhibits69: Chart on Market share By Geographical Landscape 2022-2027 (%)
  • Exhibits70: Data Table on Market share By Geographical Landscape 2022-2027 (%)
  • Exhibits71: Chart on Geographic comparison
  • Exhibits72: Data Table on Geographic comparison
  • Exhibits73: Chart on North America - Market size and forecast 2022-2027 ($ million)
  • Exhibits74: Data Table on North America - Market size and forecast 2022-2027 ($ million)
  • Exhibits75: Chart on North America - Year-over-year growth 2022-2027 (%)
  • Exhibits76: Data Table on North America - Year-over-year growth 2022-2027 (%)
  • Exhibits77: Chart on Europe - Market size and forecast 2022-2027 ($ million)
  • Exhibits78: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
  • Exhibits79: Chart on Europe - Year-over-year growth 2022-2027 (%)
  • Exhibits80: Data Table on Europe - Year-over-year growth 2022-2027 (%)
  • Exhibits81: Chart on Asia - Market size and forecast 2022-2027 ($ million)
  • Exhibits82: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
  • Exhibits83: Chart on Asia - Year-over-year growth 2022-2027 (%)
  • Exhibits84: Data Table on Asia - Year-over-year growth 2022-2027 (%)
  • Exhibits85: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
  • Exhibits86: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
  • Exhibits87: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
  • Exhibits88: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
  • Exhibits89: Chart on US - Market size and forecast 2022-2027 ($ million)
  • Exhibits90: Data Table on US - Market size and forecast 2022-2027 ($ million)
  • Exhibits91: Chart on US - Year-over-year growth 2022-2027 (%)
  • Exhibits92: Data Table on US - Year-over-year growth 2022-2027 (%)
  • Exhibits93: Chart on Germany - Market size and forecast 2022-2027 ($ million)
  • Exhibits94: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
  • Exhibits95: Chart on Germany - Year-over-year growth 2022-2027 (%)
  • Exhibits96: Data Table on Germany - Year-over-year growth 2022-2027 (%)
  • Exhibits97: Chart on UK - Market size and forecast 2022-2027 ($ million)
  • Exhibits98: Data Table on UK - Market size and forecast 2022-2027 ($ million)
  • Exhibits99: Chart on UK - Year-over-year growth 2022-2027 (%)
  • Exhibits100: Data Table on UK - Year-over-year growth 2022-2027 (%)
  • Exhibits101: Chart on Canada - Market size and forecast 2022-2027 ($ million)
  • Exhibits102: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
  • Exhibits103: Chart on Canada - Year-over-year growth 2022-2027 (%)
  • Exhibits104: Data Table on Canada - Year-over-year growth 2022-2027 (%)
  • Exhibits105: Chart on China - Market size and forecast 2022-2027 ($ million)
  • Exhibits106: Data Table on China - Market size and forecast 2022-2027 ($ million)
  • Exhibits107: Chart on China - Year-over-year growth 2022-2027 (%)
  • Exhibits108: Data Table on China - Year-over-year growth 2022-2027 (%)
  • Exhibits109: Market opportunity By Geographical Landscape ($ million)
  • Exhibits110: Impact of drivers and challenges in 2022 and 2027
  • Exhibits111: Overview on Criticality of inputs and Factors of differentiation
  • Exhibits112: Overview on factors of disruption
  • Exhibits113: Impact of key risks on business
  • Exhibits114: Vendors covered
  • Exhibits115: Matrix on vendor position and classification
  • Exhibits116: AbbVie Inc. - Overview
  • Exhibits117: AbbVie Inc. - Product / Service
  • Exhibits118: AbbVie Inc. - Key offerings
  • Exhibits119: AccuBioTech Co. Ltd. - Overview
  • Exhibits120: AccuBioTech Co. Ltd. - Product / Service
  • Exhibits121: AccuBioTech Co. Ltd. - Key offerings
  • Exhibits122: AdvaCare Pharma - Overview
  • Exhibits123: AdvaCare Pharma - Product / Service
  • Exhibits124: AdvaCare Pharma - Key offerings
  • Exhibits125: BIOGENIX Inc. Pvt. Ltd. - Overview
  • Exhibits126: BIOGENIX Inc. Pvt. Ltd. - Product / Service
  • Exhibits127: BIOGENIX Inc. Pvt. Ltd. - Key offerings
  • Exhibits128: F. Hoffmann La Roche Ltd. - Overview
  • Exhibits129: F. Hoffmann La Roche Ltd. - Business segments
  • Exhibits130: F. Hoffmann La Roche Ltd. - Key news
  • Exhibits131: F. Hoffmann La Roche Ltd. - Key offerings
  • Exhibits132: F. Hoffmann La Roche Ltd. - Segment focus
  • Exhibits133: Gilead Sciences Inc. - Overview
  • Exhibits134: Gilead Sciences Inc. - Product / Service
  • Exhibits135: Gilead Sciences Inc. - Key news
  • Exhibits136: Gilead Sciences Inc. - Key offerings
  • Exhibits137: GlaxoSmithKline Plc - Overview
  • Exhibits138: GlaxoSmithKline Plc - Business segments
  • Exhibits139: GlaxoSmithKline Plc - Key offerings
  • Exhibits140: GlaxoSmithKline Plc - Segment focus
  • Exhibits141: Hologic Inc. - Overview
  • Exhibits142: Hologic Inc. - Business segments
  • Exhibits143: Hologic Inc. - Key news
  • Exhibits144: Hologic Inc. - Key offerings
  • Exhibits145: Hologic Inc. - Segment focus
  • Exhibits146: Inovio Pharmaceuticals Inc. - Overview
  • Exhibits147: Inovio Pharmaceuticals Inc. - Product / Service
  • Exhibits148: Inovio Pharmaceuticals Inc. - Key news
  • Exhibits149: Inovio Pharmaceuticals Inc. - Key offerings
  • Exhibits150: Johnson and Johnson - Overview
  • Exhibits151: Johnson and Johnson - Business segments
  • Exhibits152: Johnson and Johnson - Key news
  • Exhibits153: Johnson and Johnson - Key offerings
  • Exhibits154: Johnson and Johnson - Segment focus
  • Exhibits155: Merck and Co. Inc. - Overview
  • Exhibits156: Merck and Co. Inc. - Business segments
  • Exhibits157: Merck and Co. Inc. - Key news
  • Exhibits158: Merck and Co. Inc. - Key offerings
  • Exhibits159: Merck and Co. Inc. - Segment focus
  • Exhibits160: OK Biotech Co. Ltd. - Overview
  • Exhibits161: OK Biotech Co. Ltd. - Product / Service
  • Exhibits162: OK Biotech Co. Ltd. - Key offerings
  • Exhibits163: Priority STD Testing - Overview
  • Exhibits164: Priority STD Testing - Product / Service
  • Exhibits165: Priority STD Testing - Key offerings
  • Exhibits166: QIAGEN NV - Overview
  • Exhibits167: QIAGEN NV - Product / Service
  • Exhibits168: QIAGEN NV - Key news
  • Exhibits169: QIAGEN NV - Key offerings
  • Exhibits170: RayBiotech Life Inc. - Overview
  • Exhibits171: RayBiotech Life Inc. - Product / Service
  • Exhibits172: RayBiotech Life Inc. - Key offerings
  • Exhibits173: Inclusions checklist
  • Exhibits174: Exclusions checklist
  • Exhibits175: Currency conversion rates for US$
  • Exhibits176: Research methodology
  • Exhibits177: Validation techniques employed for market sizing
  • Exhibits178: Information sources
  • Exhibits179: List of abbreviations